Drugs / NAc cysteine
last change Dec 2025 re-read 2 minutes ago

NAc cysteine

Developed for
amyotrophic lateral sclerosis
Investigated by
Dallas VA Medical Center

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04244630 Nov 2023 → Dec 2025 overdue amyotrophic lateral sclerosis Dallas VA Medical Center Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NAc cysteine “Over-the-counter anti-oxidants, namely vitamin E, NAc cysteine, L-cystine, Nicotinamide and Taurursodiol at defined doses” NCT04244630